Subscribe to Newsletter
QIAGEN Digital Insights Friday, June 21, 2019
We are proud to announce that QIAGEN Clinical Insight (QCI®), QIAGEN’s clinical decision support platform has achieved a milestone: over…
QIAGEN Digital Insights Thursday, June 20, 2019
QIAseq Expanded Carrier Screening Panel and industry-leading software identify genetic variants responsible for more than 200 disease indications Every year,…
QIAGEN Digital Insights Saturday, June 1, 2019
A high-throughput population screening laboratory sees significant scale-up with implementation of QIAGEN Clinical Insight (QCI®) INTRODUCTION Genetic disease is the leading…
Leif Schauser Tuesday, May 21, 2019
Introduction to the QIAseq miRNA library kit support in the Biomedical Genomics Analysis plugin for CLC Genomics Workbench The QIAseq…
Paula Tataru Thursday, May 16, 2019
Introducing the Whole Genome Alignment Plugin Paula Tataru, Ph.D, Senior Bioinformatics Scientist The new Whole Genome Alignment plugin, available for…
QIAGEN Digital Insights Wednesday, April 3, 2019
Over a quarter million germline mutations catalogued HGMD now contains 256,070 germline mutations As of March 29, 2019, HGMD contains…
Winnie Ridderberg Wednesday, March 20, 2019
In a recent blog post we shared exciting news on new functionalities for detecting antimicrobial resistance (AMR) implemented within CLC…
Thomas Poulsen Tuesday, March 19, 2019
Introduction to the Advanced Structural Variant Detection plugin for the CLC Genomics Workbench Structural variants affect large regions of the…
Leif Schauser Friday, February 15, 2019
Introduction to the Transcript Discovery Plugin Leif Schauser, PhD, Director Product Management Genome Analysis Bioinformatics – CLC Transcript discovery using…
Winnie Ridderberg Tuesday, February 5, 2019
Find resistance through surveillance and source tracing with two new tools: PointFinder and ShortBRED Winnie Ridderberg, PhD, Senior Scientist, Microbial…
QIAGEN Digital Insights Monday, February 4, 2019
As more research emerges surrounding the standardization of tumor mutational burden (TMB) assessment, a universal definition of “high TMB” across…
QIAGEN Digital Insights Sunday, February 3, 2019
Sean Scott, QIAGEN’s Chief Business Officer and Vice President of Business Development for Clinical Genomics and Bioinformatics, discusses the N-of-One…